Complex in vitro model: A transformative model in drug development and precision medicine

Author:

Wang Luming12ORCID,Hu Danping3ORCID,Xu Jinming12ORCID,Hu Jian12ORCID,Wang Yifei3

Affiliation:

1. Department of Thoracic Surgery The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou China

2. Key Laboratory of Clinical Evaluation Technology for Medical Device of Zhejiang Province Hangzhou China

3. Hangzhou Chexmed Technology Co., Ltd. Hangzhou China

Abstract

AbstractIn vitro and in vivo models play integral roles in preclinical drug research, evaluation, and precision medicine. In vitro models primarily involve research platforms based on cultured cells, typically in the form of two‐dimensional (2D) cell models. However, notable disparities exist between 2D cultured cells and in vivo cells across various aspects, rendering the former inadequate for replicating the physiologically relevant functions of human or animal organs and tissues. Consequently, these models failed to accurately reflect real‐life scenarios post‐drug administration. Complex in vitro models (CIVMs) refer to in vitro models that integrate a multicellular environment and a three‐dimensional structure using bio‐polymer or tissue‐derived matrices. These models seek to reconstruct the organ‐ or tissue‐specific characteristics of the extracellular microenvironment. The utilization of CIVMs allows for enhanced physiological correlation of cultured cells, thereby better mimicking in vivo conditions without ethical concerns associated with animal experimentation. Consequently, CIVMs have gained prominence in disease research and drug development. This review aimed to comprehensively examine and analyze the various types, manufacturing techniques, and applications of CIVM in the domains of drug discovery, drug development, and precision medicine. The objective of this study was to provide a comprehensive understanding of the progress made in CIVMs and their potential future use in these fields.

Funder

National Key Research and Development Program of China

Science and Technology Program of Zhejiang Province

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Reference110 articles.

1. Organ‐on‐a‐chip: A new paradigm for drug development;Ma C;Trends Pharmacol Sci,2021

2. An overview of drug discovery and development;Berdigaliyev N;Future Med Chem,2020

3. Key concepts of clinical trials: a narrative review;Umscheid CA;Postgrad Med,2011

4. Cancer cell lines for drug discovery and development;Wilding JL;Cancer Res,2014

5. Perspectives on the evaluation and adoption of complex in vitro models in drug development: workshop with the FDA and the pharmaceutical industry (IQ MPS affiliate);Baran SW;ALTEX,2022

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Microfluidic systems for modeling digestive cancer: a review of recent progress;Biomedical Physics & Engineering Express;2024-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3